Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injury.

Archive ouverte

Curtit, Elsa | Chaigneau, Loïc | Pauchot, Julien | Nguyen, Thierry | Nerich, Virginie | Bazan, Fernando | Thiery-Vuillemin, Antoine | Demarchi, Martin | Pivot, Xavier | Villanueva, Cristian

Edité par CCSD ; International Institute of Anticancer Research -

International audience. Anthracycline extravasation is an uncommon but very serious complication. Very few data are available in the literature concerning the consequences and the management of extravasation of liposomal doxorubicin. This report describes the cases of two patients with liposomal doxorubicin extravasation who developed irritant reaction without vesicant or necrotic lesions. It is concordant with other cases described in the literature and suggests that extravasation of liposomal doxorubicin can be relatively well tolerated. The process applied to extravasations of irritant and non-vesicant agents could be used to manage extravasations of liposomal doxorubicin.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion